905611000001107: Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Trade family\Lamisil\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16317301000001118 Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

16317401000001114 Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Terbinafine hydrochloride	false	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Local anti-infective	false	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Skin anti-infective	false	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Lamisil	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Terbinafine	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Terbinafine hydrochloride	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Has basis of strength substance	Terbinafine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet	Is pack of	False	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Is pack of	False	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet	Has AMP	True	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16317301000001118	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16317401000001114	Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module